Switch to:

Bed Bath & Beyond Inc (BBBY)Ownership Data

Short Interest History (%)

This is the historical short interest of Bed Bath & Beyond Inc, as measured by the Short Percentage Of Float.

Institutional Ownership History (%)

This the Institutional Ownership History of Bed Bath & Beyond IncPeter Lynch prefers to buy companies with low institutional ownership.

Insider ownership (%)

This is the historical insider ownership of Bed Bath & Beyond Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Mr. Leonard FeinsteinCo-Chairman937,8060.51%2015-01-12
Mr. Warren EisenbergCo-Chairman648,4630.35%2015-01-12
Mr. Steven H. TemaresCEO, Director544,3650.29%2014-05-12
Mr. Arthur StarkPresident and CMO155,779less than 0.1%2014-11-13
Mr. Eugene A. CastagnaCOO134,761less than 0.1%2014-11-14
Mr. Matthew FiorilliSenior VP - Stores124,987less than 0.1%2015-01-16
Susan E. LattmannCFO and Treasurer26,718less than 0.1%2014-05-12
Mr. Dean S. AdlerN/A23,364less than 0.1%2014-07-07
Mr. Stanley F. BarshayDirector22,419less than 0.1%2014-07-07
Mr. Jordan HellerN/A15,076less than 0.1%2014-07-07

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value
Brown Brothers Harriman & Co10,476,6642014-09-305.662.78689,679,000
Vanguard Group, Inc.10,119,7622014-09-305.460.05666,183,000
Fidelity Management and Research Company9,743,7922014-09-305.260.09641,434,000
State Street Corp9,178,4822014-09-304.950.07604,205,000
Fidelity® Low-Priced Stock Fund6,385,8002014-10-313.450.93430,019,772
BlackRock Fund Advisors6,246,0482014-09-303.370.06411,178,000
MFS Investment Management K.K.5,916,5162014-09-303.190.21389,485,000
J.P. Morgan Investment Management Inc.5,559,9682014-09-303.000.17366,013,000
Cornerstone Investment Partners LLC5,497,6332014-09-302.974.03361,909,000
Hotchkis & Wiley Capital Management LLC4,581,3752014-09-302.471.09301,592,000

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

Pravchaw
ReplyPravchaw - 6 months ago
Could you please add back interest_expense and interest_income series to interactive chart. I'd like to construct a customized series for cash return - http://news.morningstar.com/classroom2/course.asp?docId=145100&page=10&CN=
Jlmay86
ReplyJlmay86 - 6 months ago
Current market price (59.35) showing that the market expects ONLY a 2% growth of BBBY's TTM EPS for the next 45 years (discounted 10%)... really?!
Chentao1006
ReplyChentao1006 - 7 months ago
test
Chentao1006
ReplyChentao1006 - 7 months ago
test
SEENSCO
ReplySEENSCO - 7 months ago
hahahah...that;s definitely not what we're talking about.

Our investment philosophy is consistent with that of Benjamin Graham in that we are seeking investments that offer safety of principal and exceptional returns.

When coverage is added on a company, we run it through a series of 7 "safety-first" screens. Only when a business passes these screens, or at least most of them, will it offer sufficient safety to qualify for investment. To read more about the screens please visit our website: www.seensco.com

Cheers
Gurufocus
ReplyGurufocus - 7 months ago
test
Svartholm
ReplySvartholm - 7 months ago
SEENSCO,
What's a safety-first screen? :) (BBBY actually sells a product called "safety 1st screen door saver" but i'll assume that's not what you're talking about)
SEENSCO
ReplySEENSCO - 7 months ago
Long-term earnings are well intact, great fundamentals, minimal balance sheet risk, and passes 6 of 7 "Safety-First Screens."
Ashimkar
ReplyAshimkar - 7 months ago
What is so exciting about this? Insiders are selling....
SEENSCO
ReplySEENSCO - 7 months ago
Thanks for this one Mr Market!

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK